BTK Inhibitors for the Treatment of FL

In this video capsule, Dr. Laurie Sehn leads a discussion with Dr. Judith Trotman on the topic of BTK inhibitors for the treatment of Follicular Lymphoma (FL). Future outlooks for the treatment of FL are also discussed. Our Guests: Dr. Laurie Sehn is a Clinical Assistant Professor in the Department of Medicine at the University of British Columbia. She has been a medical oncologist and clinical investigator at the BC Cancer Agency since 1998 and is currently the Chair of the Lymphoma Tumour Group. Dr. Sehn is Chair of the medical advisory board for the International Lymphoma Coalition and also serves as co-chair of the Lymphoma Site of the Canadian Cancer Trials Group. Dr. Judith Trotman is a clinical and laboratory Hematologist, at Concord Repatriation General Hospital, University of Sydney. Her research interests have focused on the introduction of novel targeted therapies aiming to improve survival and quality of life for patients with indolent lymphoma. She is the Chair of the Australasian Leukaemia Lymphoma Group (ALLG). Committed to DEI in lymphoma research, she was the Founder of Women in Lymphoma. This video capsule was sponsored by BeiGene Canada ULC If you enjoyed this video, please like and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.com/